Stoke Therapeutics (STOK) Return on Equity: 2022-2025
Historic Return on Equity for Stoke Therapeutics (STOK) over the last 3 years, with Sep 2025 value amounting to 0.13%.
- Stoke Therapeutics' Return on Equity rose 57.00% to 0.13% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.13%, marking a year-over-year increase of 57.00%. This contributed to the annual value of -0.46% for FY2024, which is 15.00% up from last year.
- According to the latest figures from Q3 2025, Stoke Therapeutics' Return on Equity is 0.13%, which was down 17.75% from 0.15% recorded in Q2 2025.
- Over the past 5 years, Stoke Therapeutics' Return on Equity peaked at 0.17% during Q1 2025, and registered a low of -0.72% during Q1 2024.
- Over the past 3 years, Stoke Therapeutics' median Return on Equity value was -0.50% (recorded in 2023), while the average stood at -0.35%.
- In the last 5 years, Stoke Therapeutics' Return on Equity fell by 23bps in 2024 and then surged by 90bps in 2025.
- Quarterly analysis of 4 years shows Stoke Therapeutics' Return on Equity stood at -0.52% in 2022, then decreased by 11bps to -0.63% in 2023, then grew by 24bps to -0.39% in 2024, then skyrocketed by 57bps to 0.13% in 2025.
- Its Return on Equity was 0.13% in Q3 2025, compared to 0.15% in Q2 2025 and 0.17% in Q1 2025.